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Abstract
Genome-wide association studies have successfully identified numerous loci at which common variants influence
disease risks or quantitative traits of interest. Despite these successes, the variants identified by these studies have
generally explained only a small fraction of the variations in the phenotype. One explanation may be that many
rare variants that are not included in the common genotyping platforms may contribute substantially to the
genetic variations of the diseases. Next-generation sequencing, which would better allow for the analysis of rare
variants, is now becoming available and affordable; however, the presence of a large number of rare variants
challenges the statistical endeavor to stably identify these disease-causing genetic variants. We conduct a genome-
wide association study of Genetic Analysis Workshop 17 case-control data produced by the next-generation
sequencing technique and propose that collapsing rare variants within each genetic region through a supervised
dimension reduction algorithm leads to several macrovariants constructed for rare variants within each genetic
region. A simultaneous association of the phenotype to all common variants and macrovariants is undertaken
using a linear discriminant analysis using the penalized orthogonal-components regression algorithm. The results
suggest that the proposed analysis strategy shows promise but needs further development.
Background
Although genome-wide association studies (GWAS) are
becoming a powerful tool to discover causal genes of
common diseases, it has been hotly debated whether
common diseases are caused by common variants or
multiple rare variants. Nowadays, more evidence sup-
porting the role of rare variants in disease association
(especially for Mendelian disorders) can be found in the
literature. Through the advances in next-generation
sequencing techniques, it is possible to incorporate rare
variants into association studies. In GWAS, the ability
to detect an association at a particular single-nucleotide
polymorphism (SNP) decreases with the minor allele
frequency (MAF) of that SNP; as a result, studies have
so far been underpowered to detect associations with
rare variants, and so alternative approaches are required.
A natural approach is a collapsing strategy in which
rare variants within a defined group are collapsed into a
single variant. Individually, low-frequency variants are
rare, but within aggregates they may be common
enough to account for variations in common traits,
which is the basic idea behind the collapsing methods
[1]. Li and Leal [2] proposed collapsing rare variants
within each genetic region by indicating the presence of
the minor allele. Madsen and Browning [3] then pro-
posed a weighted-sum statistic in which variants were
weighted according to their frequency in the unaffected
sample, with low-frequency variants being weighted
more heavily. With most of the existing collapsing
methods using an unsupervised dimension reduction
algorithm, at this point we propose to collapse rare var-
iants within each genetic region through a partial least-
squares (PLS) regression, which is a supervised dimen-
sion reduction algorithm that leads to several “macro-
variants” constructed for the rare variants within each
genetic region [4].
A simultaneous study of the phenotypic association of
all common variants and macrovariants will generate
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investigations.
With the available common variants and macrovar-
iants, we conduct the genome-wide case-control study
by using a linear discriminant analysis (LDA). The LDA
is implemented using the penalized orthogonal-compo-
nents regression (POCRE) algorithm, which sequentially
constructs sparsely loaded orthogonal components with
proper regularization. The superior performance of the
POCRE algorithm in fitting regression models with large
p and small n data, as shown by Zhang et al. [5], allows
us to reliably identify the potential disease-causing
genetic variants out of a great number of candidates.
We applied the POCRE algorithm to the genome-wide
association study of the binary trait in the Genetic Ana-
lysis Workshop 17 (GAW17) data using both common
variants and macrovariants constructed using a PLS
regression.
Methods
Collapsing rare variants within each genetic region
Here, we use the PLS regression, which is a supervised
dimension reduction approach, to help collapse the rare
variants within each genetic region. Consider the follow-
ing model for each gene:
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where Y is the phenotype vector and {X1, …, Xk}a r e
the genotypes of k rare variants within the gene. The
PLS regression is used to find a set of components that
are linear combinations of the Xj with the constraint
that these components explain as much as possible the
covariance between Y and X. Cross validation is used to
determine the optimal number of components for each
gene.
Linear discriminant analysis using penalized orthogonal-
components regression
As shown by Zhang et al. [5], the POCRE algorithm
sequentially constructs orthogonal components to
maximize, upon standardization, their correlation to
the response residuals; at the same time, the algorithm
uses a penalization by means of empirical Bayes
thresholding [6] to effectively identify sparse predictors
for each component. The POCRE algorithm is compu-
tationally efficient because of its sequential construc-
tion of leading sparse principal components. In
addition, this construction offers other distinct proper-
ties, such as the ability to group highly correlated pre-
dictors and to allow for collinear or nearly collinear
predictors.
Consider the following multiple linear regression:
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where Y is the phenotype vector of length n, X is an n
× p genotype matrix, bj is the additive effect of that
genetic variant, j =1 ,…, p, n is the number of indivi-
duals, and p is the number of SNPs. We then further
assume that Y and X a r ec e n t e r e da t0a n dt h a tt h e
POCRE algorithm sequentially constructs the orthogonal
components
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subject to ||a|| = 1, where gg(g) is a penalty function
defined by a proper regularization on g with tuning
parameter l. Zhang et al. [5] used empirical Bayes
thresholding methods, as proposed by Johnstone and
Silverman [6], to introduce the proper penalty gg(g).
In this case-control genome-wide association study,
the LDA is implemented with the POCRE algorithm.
First, we define Yi = 1 if individual i is from the case
population, and Yi = −1o t h e r w i s e .S e c o n d ,t h eL D Ai s
implemented with the threshold c = 0 by regressing the
phenotype vector Y =( y1, …, yn)
T against X using the
POCRE algorithm. The design matrix X here contains
the genotypic values of both common variants and
macrovariants constructed by the PLS regression. The
tuning parameter l is elicited by using a testing data set
with candidates from 0.8 to 0.9, with a step size of 0.01.
To prevent using the same data twice, a process that
results in overfitting, we selected one out of 200 pheno-
type replicates and applied the PLS regression to col-
lapse rare variants to obtain the macrovariants for each
gene. We then used results from the PLS regression to
analyze another phenotype replicate using the POCRE
algorithm. This is not the case in real data analysis, and
we suggest taking a traditional approach to splitting the
data into training and testing sets, even though we may
suffer a reduction in power by reducing sample size.
When the sample size is a concern, we recommend
using the whole data set twice, the first time for collap-
sing rare variants and the second time for association
study, even though it may magnify the type I error.
Data set and preprocessing
Finally, we applied the proposed methods to the binary
trait in the GAW17 data. All 697 individuals were kept
for our analysis after preprocessing the data using
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variants into three categories: SNPs with MAF ≥ 0.05,
SNPs with 0.005 ≤ MAF < 0.05 but no other SNPs
within the corresponding genetic regions, and macrovar-
i a n t sf o rg e n e sw i t hm u l t i p l er a r eS N P s .T h r e eo t h e r
factors—Age, Sex, and Smoke—were also used to con-
trol environmental effects. For detailed data information,
see [8].
Results
We used LDA with the POCRE algorithm to analyze
each of the 200 replicates, and we report the SNPs and
genes that appeared frequently across all 200 replicates.
In our association study, we have two types of genetic
variants: the SNPs and the macrovariants. If a SNP is
found to be significant, it is reported as a significant
SNP; alternately, if any macrovariants representing that
gene are found to be significant, then a significant gene
is reported. The frequency of nonzero estimated effects
out of the 200 replicates is calculated for both SNPs and
genes.
In Table 1 we list the SNPs detected in six or more
replicates along with the gene in which they reside.
Three of the detected SNPs lead us to the casual genes;
they are C13S523 (corresponding to gene FLT1),
C8S890 (PTK2B), and C6S5380 (VNN1). However, we
noticed that only C13S523 and C6S5380 are true dis-
ease-related SNPs; C13S523 has a moderate MAF
(0.066714) and a large effect size (0.64997), whereas
C6S5380 has a large MAF (0.170732) but a moderate
effect size (0.24437). Surprisingly, SNP C8S890, which is
not in the simulation model, guides us to disease gene
PTK2B; this finding might be due to the linkage disequi-
librium between SNPs within the gene.
Out of the 200 replicates, a handful of genes found
through macrovariants have a high frequency of nonzero
estimated effects. Both the genes and the environmental
covariates detected in 10 or more replicates are listed in
Table 2. Among our findings, FLT1, PTK2B, VNN1, and
PIK3C3 are the true casual genetic variants along with
two significant environmental factors, Age and Smoke.
We have noticed that FLT1 is detected twice, once
through the common SNP C13S523 and once through
the macrovariants constructed by rare variants within
the gene.
Discussion and conclusions
Using our developed approach for GWAS, we were able
to find a few true associations, but our results still suffer
from limited power and a high false-positive rate. We
detected the disease gene PIK3C3 by collapsing rare var-
iants within genes using PLS regression, and the pro-
posed strategy may gain power through collapsing. Even
though we had some success in this study, we are still
concerned about the possible low power when applying
this method. In fact, association studies become even
more difficult when most of the causal genetic effects
are due to rare variants, especially when some of them
are extremely rare variants (i.e., rare alleles that are
observed in only a few subjects). Compared to pheno-
type Q1 and Q2 in the GAW17 data, the binary trait
has relatively low effect size, which makes it even more
difficult to detect its signals through this research.
Therefore more powerful strategies need to be further
investigated in order to effectively associate rare variants
with binary traits.
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Table 1 SNPs with high frequencies of nonzero estimated
effects
SNP Gene Chromosome Frequency (%)
C13S523* FLT1 13 41
C12S707 PRR4 12 6.5
C12S708 PRR4 12 6
C12S706 PRR4 12 5.5
C12S709 TAS2R48 12 5.5
C8S890* PTK2B 8 3.5
C12S705 TAS2R48 12 3.5
C16S3298 CCDC135 16 3.5
C6S5380* VNN1 63
C19S2864 ZNF91 19 3
The Gene column lists the genes in which the corresponding SNP resides.
Asterisks indicate true causal SNPs.
Table 2 Genes with high frequencies of nonzero
estimated effects
Gene Chromosome Frequency (%)
Age* NA 100
Smoke* NA 92
FLT1* 13 17.5
PIK3C3* 18 10
PRR4 12 5.5
SPHKAP 2 5.5
RUNX2 65
Asterisks denote the true causal genes or environmental factors.
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